Molecular Neurodegeneration,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: Nov. 8, 2023
Abstract
DNA
sensing
is
a
pivotal
component
of
the
innate
immune
system
that
responsible
for
detecting
mislocalized
and
triggering
downstream
inflammatory
pathways.
Among
sensors,
cyclic
GMP-AMP
synthase
(cGAS)
primary
player
in
cytosolic
DNA,
including
foreign
from
pathogens
self-DNA
released
during
cellular
damage,
culminating
type
I
interferon
(IFN-I)
response
through
stimulator
genes
(STING)
activation.
IFN-I
cytokines
are
essential
mediating
neuroinflammation,
which
widely
observed
CNS
injury,
neurodegeneration,
aging,
suggesting
an
upstream
role
cGAS
pathway.
In
this
review,
we
summarize
latest
developments
on
cGAS-STING
DNA-driven
various
neurological
diseases
conditions.
Our
review
covers
current
understanding
molecular
mechanisms
activation
highlights
signaling
cell
types
central
peripheral
nervous
systems,
such
as
resident
brain
cells,
neurons,
glial
cells.
We
then
discuss
different
neurodegenerative
conditions,
tauopathies,
Alzheimer’s
disease,
Parkinson’s
amyotrophic
lateral
sclerosis,
well
aging
senescence.
Finally,
lay
out
advancements
research
development
inhibitors
assess
prospects
targeting
STING
therapeutic
strategies
wide
spectrum
diseases.
Microbiome,
Journal Year:
2021,
Volume and Issue:
9(1)
Published: Nov. 11, 2021
Abstract
Background
Cognitive
impairment,
an
increasing
mental
health
issue,
is
a
core
feature
of
the
aging
brain
and
neurodegenerative
diseases.
Industrialized
nations
especially,
have
experienced
marked
decrease
in
dietary
fiber
intake,
but
potential
mechanism
linking
low
intake
cognitive
impairment
poorly
understood.
Emerging
research
reported
that
diversity
gut
microbiota
Western
populations
significantly
reduced.
However,
it
unknown
whether
fiber-deficient
diet
(which
alters
microbiota)
could
impair
cognition
functional
elements
through
gut-brain
axis.
Results
In
this
study,
mouse
model
long-term
(15
weeks)
deficiency
(FD)
was
used
to
mimic
sustained
humans.
We
found
FD
mice
showed
impaired
cognition,
including
deficits
object
location
memory,
temporal
order
ability
perform
daily
living
activities.
The
hippocampal
synaptic
ultrastructure
damaged
mice,
characterized
by
widened
clefts
thinned
postsynaptic
densities.
A
proteomic
analysis
further
identified
deficit
CaMKIId
its
associated
proteins
(including
GAP43
SV2C)
along
with
neuroinflammation
microglial
engulfment
synapses.
also
exhibited
dysbiosis
(decreased
Bacteroidetes
increased
Proteobacteria),
which
deficits.
Of
note,
rapid
differentiating
change
observed
short-term
(7
days)
before
highlighting
possible
causal
impact
profile
on
outcomes.
Moreover,
compromised
intestinal
barrier
reduced
short-chain
fatty
acid
(SCFA)
production.
exploit
these
findings
for
SCFA
receptor
knockout
oral
supplementation
verified
playing
critical
role
altered
impairment.
Conclusions
This
first
time,
reports
fiber-deprived
leads
altering
microbiota-hippocampal
axis,
pathologically
distinct
from
normal
aging.
These
alert
adverse
function,
highlight
increase
as
nutritional
strategy
reduce
risk
developing
diet-associated
decline
Cells,
Journal Year:
2022,
Volume and Issue:
11(12), P. 1885 - 1885
Published: June 10, 2022
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
disorder
molecularly
characterized
by
the
formation
of
amyloid
β
(Aβ)
plaques
and
type
2
microtubule-associated
protein
(Tau)
abnormalities.
Multiple
studies
have
shown
that
many
brain’s
immunological
cells,
specifically
microglia
astrocytes,
are
involved
in
AD
pathogenesis.
Cells
innate
immune
system
play
an
essential
role
eliminating
pathogens
but
also
regulate
brain
homeostasis
AD.
When
activated,
cells
can
cause
programmed
cell
death
through
multiple
pathways,
including
pyroptosis,
apoptosis,
necroptosis,
PANoptosis.
The
often
results
release
proinflammatory
cytokines
propagate
response
eliminate
Aβ
aggregated
Tau
proteins.
However,
chronic
neuroinflammation,
which
result
from
death,
has
been
linked
to
diseases
worsen
Therefore,
must
be
tightly
balanced
appropriately
clear
these
AD-related
structural
abnormalities
without
inducing
neuroinflammation.
In
this
review,
we
discuss
responses,
inflammatory
cytokine
secretion
as
they
relate
Therapeutic
strategies
targeting
mechanisms
will
critical
consider
for
future
preventive
or
palliative
treatments
Cells,
Journal Year:
2020,
Volume and Issue:
9(11), P. 2360 - 2360
Published: Oct. 27, 2020
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
novel
human
that
has
sparked
global
pandemic
of
the
disease
2019
(COVID-19).
The
virus
invades
cells
through
angiotensin-converting
enzyme
(ACE2)
receptor-driven
pathway,
primarily
targeting
tract.
However,
emerging
reports
neurological
manifestations
demonstrate
neuroinvasive
potential
SARS-CoV-2.
This
review
highlights
possible
routes
by
which
SARS-CoV-2
may
invade
central
nervous
system
(CNS)
and
provides
insight
into
recent
case
COVID-19-associated
disorders,
namely
ischaemic
stroke,
encephalitis,
encephalopathy,
epilepsy,
neurodegenerative
diseases,
inflammatory-mediated
disorders.
We
hypothesize
neuroinvasion,
neuroinflammation,
blood-brain
barrier
(BBB)
dysfunction
be
implicated
in
development
observed
disorders;
however,
further
research
critical
to
understand
detailed
mechanisms
pathway
infectivity
behind
CNS
pathogenesis.
Nature Neuroscience,
Journal Year:
2023,
Volume and Issue:
26(5), P. 737 - 750
Published: April 24, 2023
Pathological
hallmarks
of
Alzheimer's
disease
(AD)
precede
clinical
symptoms
by
years,
indicating
a
period
cognitive
resilience
before
the
onset
dementia.
Here,
we
report
that
activation
cyclic
GMP-AMP
synthase
(cGAS)
diminishes
decreasing
neuronal
transcriptional
network
myocyte
enhancer
factor
2c
(MEF2C)
through
type
I
interferon
(IFN-I)
signaling.
Pathogenic
tau
activates
cGAS
and
IFN-I
responses
in
microglia,
part
mediated
cytosolic
leakage
mitochondrial
DNA.
Genetic
ablation
Cgas
mice
with
tauopathy
diminished
microglial
response,
preserved
synapse
integrity
plasticity
protected
against
impairment
without
affecting
pathogenic
load.
increased,
while
decreased,
MEF2C
expression
linked
to
AD.
Pharmacological
inhibition
enhanced
restored
synaptic
integrity,
memory,
supporting
therapeutic
potential
targeting
cGAS-IFN-MEF2C
axis
improve
AD-related
pathological
insults.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: Sept. 30, 2021
The
coronavirus
disease-19
(COVID-19)
elicited
by
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
has
caused
devastating
health,
economic
and
social
impact
worldwide.
Its
clinical
spectrum
ranges
from
asymptomatic
to
failure
multi-organ
or
death.
pathogenesis
of
SARS-CoV-2
infection
is
attributed
a
complex
interplay
between
virus
host
immune
response.
It
involves
activation
multiple
inflammatory
pathways
leading
hyperinflammation
cytokine
storm,
resulting
in
tissue
damage,
distress
(ARDS)
failure.
Accumulating
evidence
raised
concern
over
long-term
health
effects
COVID-19.
Importantly,
neuroinvasive
potential
may
have
consequences
brain.
This
review
provides
conceptual
framework
on
how
tricks
system
induce
cause
disease.
We
also
explore
key
differences
mild
COVID-19
its
short-
effects,
particularly
human